IRIS
SCIORTINO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 484
EU - Europa 87
AS - Asia 79
AF - Africa 1
Totale 651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 483
SG - Singapore 60
UA - Ucraina 34
IT - Italia 18
FI - Finlandia 16
CN - Cina 11
SE - Svezia 6
DE - Germania 5
KR - Corea 5
BE - Belgio 2
GB - Regno Unito 2
CA - Canada 1
HU - Ungheria 1
IN - India 1
KE - Kenya 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
VN - Vietnam 1
Totale 651
Salva come PNG Salva come JPEG
Città #
Chandler 209
Singapore 52
Princeton 38
Mountain View 15
Wilmington 14
Espoo 9
Ashburn 8
Santa Clara 6
Helsinki 5
Quartucciu 5
Seoul 5
Dallas 4
Ann Arbor 3
Jacksonville 3
Nanchang 3
San Francisco 3
Brussels 2
Lappeenranta 2
London 2
Romola 2
Taizhou 2
Washington 2
Beijing 1
Boardman 1
Budapest 1
Clearwater 1
Falls Church 1
Hangzhou 1
Hebei 1
Hyderabad 1
Iasi 1
Milan 1
Munich 1
Nairobi 1
Nanjing 1
Norwalk 1
Reston 1
Sassari 1
Seattle 1
Shijiazhuang 1
Toronto 1
Xuzhou 1
Totale 414
Salva come PNG Salva come JPEG
Nome #
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 43
Quantitative prediction of electronic absorption spectra of copper(II)–bioligand systems: Validation and applications 42
Covalent and non-covalent binding in vanadium–protein adducts 41
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 38
Stepwise Oxidations in a Cofacial Copper(II) Porphyrin Dimer: Through-Space Spin-Coupling and Interplay between Metal and Radical Spins 36
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 32
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 31
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 31
Through-Space Spin Coupling in a Silver(II) Porphyrin Dimer upon Stepwise Oxidations: AgII⋅⋅⋅AgII, AgII⋅⋅⋅AgIII, and AgIII⋅⋅⋅AgIII Metallophilic Interactions 30
The binding modes of VIVO2+ions in blood proteins and enzymes 29
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 29
Polyoxovanadates with emerging biomedical activities 29
Binding of vanadium ions and complexes to proteins and enzymes in aqueous solution 28
Integrated experimental/computational approaches to characterize the systems formed by vanadium with proteins and enzymes 27
New VIV, VIVO, VVO, and VVO2Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity 25
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 24
Ferromagnetic Coupling in Oxidovanadium(IV)-Porphyrin Radical Dimers 24
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 24
Polyoxidovanadates' interactions with proteins: An overview 21
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 19
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 17
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity 13
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 8
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 8
Solution chemistry of oxidovanadium(IV) complexes with two bis-kojic acid derivatives 8
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 8
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 7
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 6
Interaction of VIVO–8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 6
Protein‐Protein Stabilization in VIVO/8‐Hydroxyquinoline–Lysozyme Adducts 4
Experimental and Computational Studies on the Interaction of DNA with Hesperetin Schiff Base CuII Complexes 3
Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands 2
Totale 693
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 1 0 2 0 2 0 1 0
2020/202155 1 0 1 0 1 2 18 6 13 13 0 0
2021/202297 4 0 0 0 9 1 2 9 10 8 7 47
2022/2023332 32 42 16 57 20 48 0 42 64 1 8 2
2023/202491 18 7 4 8 20 4 0 3 4 0 10 13
2024/2025105 4 8 45 25 23 0 0 0 0 0 0 0
Totale 693